Prostate Cancer Reports

Volume 7 Number 3
March 2019


Home > Disciplines > Prostate Cancer Reports > Volume 7, Year 2019 > Number 3, March



CONTENTS


DIAGNOSIS
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



DIAGNOSIS

.

Billis A, Freitas LLL, Costa LBE, Barreto IS, Magna LA, Matheus WE, Ferreira U.
The TNM 8th edition: Validation of the proposal for organ - confined (pT2) prostate cancer.
Int Braz J Urol. 2018 Nov 30;45. doi: 10.1590/S1677-5538.IBJU.2018.0338. [Epub ahead of print]
Source | Full text | Similar articles



.

Boesen L, Nørgaard N, Løgager V, Balslev I, Bisbjerg R, Thestrup KC, Winther MD, Jakobsen H, Thomsen HS.
Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.
JAMA Netw Open. 2018 Jun 1;1(2):e180219. doi: 10.1001/jamanetworkopen.2018.0219.
Source | Full text | Similar articles



.

Calais J, Czernin J, Fendler WP, Elashoff D, Nickols NG.
Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT].
BMC Cancer. 2019 Jan 7;19(1):18. doi: 10.1186/s12885-018-5200-1. Erratum in: BMC Cancer. 2019 Jan 21;19(1):97.
Source | Full text | Similar articles



.

Ferraro DA, Rupp NJ, Donati OF, Messerli M, Eberli D, Burger IA.
68Ga-PSMA-11 PET/MR Can Be False Positive in Normal Prostatic Tissue.
Clin Nucl Med. 2019 Jan 1. doi: 10.1097/RLU.0000000000002473. [Epub ahead of print]
Source | Abstract | Similar articles



.

Gordetsky JB, Ullman D, Schultz L, Porter KK, Del Carmen Rodriguez Pena M, Calderone CE, Nix JW, Ullman M, Bae S, Rais-Bahrami S.
Histologic findings associated with false-positive multiparametric magnetic resonance imaging performed for prostate cancer detection.
Hum Pathol. 2019 Jan;83:159-165. doi: 10.1016/j.humpath.2018.08.021. Epub 2018 Sep 1.
Source | Full text | Similar articles



.

Jilg CA, Drendel V, Rischke HC, Beck TIR, Reichel K, Krönig M, Wetterauer U, Schultze-Seemann W, Meyer PT, Vach W.
Detection Rate of 18F-choline-PET/CT and 68Ga-PSMA-HBED-CC-PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.
J Nucl Med. 2019 Jan 25. pii: jnumed.118.220541. doi: 10.2967/jnumed.118.220541. [Epub ahead of print]
Source | Full text | Similar articles



.

Mehralivand S, Shih JH, Harmon S, Smith C, Bloom J, Czarniecki M, Gold S, Hale G, Rayn K, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.
A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
Radiology. 2019 Jan 22:181278. doi: 10.1148/radiol.2018181278. [Epub ahead of print]
Source | Full text | Similar articles



.

Shah PH, Patel VR, Moreira DM, George AK, Alom M, Kozel Z, Joshi V, Ben-Levi E, Villani R, Yaskiv O, Kavoussi LR, Vira M, Olsson CO, Rastinehad AR.
Implementation of multiparametric magnetic resonance imaging technology for evaluation of patients with suspicion for prostate cancer in the clinical practice setting.
BJU Int. 2019 Feb;123(2):239-245. doi: 10.1111/bju.14515. First published: 16 August 2018.
Source | Full text | Similar articles



.

Zhang J, Shao S, Wu P, Liu D, Yang B, Han D, Li Y, Lin X, Song W, Cao M, Zhang J, Kang F, Qin W, Wang J.
Diagnostic performance of 68Ga-PSMA PET/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms.
Eur J Nucl Med Mol Imaging. 2019 Jan 11. doi: 10.1007/s00259-018-4255-1. [Epub ahead of print]
Source | Full text | Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY

.

Cheng Y, Tang XY, Li YX, Zhao DD, Cao QH, Wu HX, Yang HB, Hao K, Yang Y.
Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells.
Clin Cancer Res. 2018 Nov 30. doi: 10.1158/1078-0432.CCR-18-2912. [Epub ahead of print]
Source | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE

.

Robinson D, Garmo H, Van Hemelrijck M, Damber JE, Bratt O, Holmberg L, Wahlund LO, Stattin P, Adolfsson J.
Androgen deprivation therapy for prostate cancer and risk of dementia.
BJU Int. 2019 Jan 13. doi: 10.1111/bju.14666. [Epub ahead of print]
Source | Full text | Similar articles



.

Sureda A, Fumadó L, Ferrer M, Garín O, Bonet X, Castells M, Mir MC, Abascal JM, Vigués F, Cecchini L, Suárez JF.
Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
Health Qual Life Outcomes. 2019 Jan 14;17(1):11. doi: 10.1186/s12955-019-1082-4.
Source | Full text | Similar articles



INTEGRATIVE MEDICINE

.

Gregg JR, Zheng J, Lopez DS, Reichard C, Browman G, Chapin B, Kim J, Davis J, Daniel CR.
Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance.
Br J Cancer. 2019 Jan 25. doi: 10.1038/s41416-019-0380-2. [Epub ahead of print]
Source | Full text | Similar articles



.

Hao Q, Gong H, Zong H, Huang S, Wang T, Zhou Y, Zhang Y, Zhang Y.
Aspirin use improves the biochemical control of prostate cancer in Chinese men.
J BUON. 2018 Nov-Dec;23(6):1803-1808.
Source | Full text | Similar articles



.

Kukko V, Kaipia A, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ.
Allopurinol and the risk of prostate cancer in a Finnish population-based cohort.
Prostate Cancer Prostatic Dis. 2019 Jan 29. doi: 10.1038/s41391-019-0129-2. [Epub ahead of print]
Source | Full text | Similar articles



OVERALL MANAGEMENT

.

Osowiecka K, Nawrocki S, Kurowicki M, Rucinska M.
The Waiting Time of Prostate Cancer Patients in Poland.
Int J Environ Res Public Health. 2019 Jan 26;16(3). pii: E342. doi: 10.3390/ijerph16030342.
Source | Full text | Similar articles



PROGNOSIS

.

Kim R, Kim CK, Park JJ, Kim JH, Seo SI, Jeon SS, Lee HM.
Prognostic Significance for Long-Term Outcomes Following Radical Prostatectomy in Men with Prostate Cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2.
Korean J Radiol. 2019 Feb;20(2):256-264. doi: 10.3348/kjr.2018.0613.
Source | Full text | Similar articles



.

Li T, Sun X, Chen L.
Free testosterone value before radical prostatectomy is related to oncologic outcomes and post-operative erectile function.
BMC Cancer. 2019 Jan 18;19(1):87. doi: 10.1186/s12885-018-5148-1.
Source | Full text | Similar articles



.

Martini A, Gupta A, Cumarasamy S, Lewis SC, Haines KG 3rd, Briganti A, Montorsi F, Tewari AK.
Novel nomogram for the prediction of seminal vesicle invasion including multiparametric magnetic resonance imaging.
Int J Urol. 2019 Jan 18. doi: 10.1111/iju.13905. [Epub ahead of print]
Source | Full text | Similar articles



.

Mima T, Ohori M, Hirasawa Y, Mikami R, Arai A, Hashimoto T, Satake N, Gondo T, Nakagami Y, Namiki K, Tokuuye K, Ohno Y.
Salvage radiation therapy for prostate cancer patients after prostatectomy.
Jpn J Clin Oncol. 2019 Jan 4. doi: 10.1093/jjco/hyy195. [Epub ahead of print]
Source | Full text | Similar articles



.

Viani GA, Hamamura AC, Correa AC, de Arruda FT.
Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
Int Braz J Urol. 2019 Jan 5;45. doi: 10.1590/S1677-5538.IBJU.2018.0039. [Epub ahead of print]
Source | Full text | Similar articles



.

Yaxley JW, Raveenthiran S, Nouhaud FX, Samartunga H, Yaxley AJ, Coughlin G, Delahunt B, Egevad L, McEwan L, Wong D.
Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with 68Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node Pathology: Can Preoperative 68Ga-PSMA Positron Emission Tomography/Computerized Tomography Replace Pelvic Lymph Node Dissection for Prostate Cancer Staging?
J Urol. 2019 Jan 21. doi: 10.1097/JU.0000000000000053. [Epub ahead of print]
Source | Abstract | Similar articles



TREATMENT

.

Gupta M, Patel HD, Schwen ZR, Tran PT, Partin AW.
Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit.
BJU Int. 2019 Feb;123(2):252-260. doi: 10.1111/bju.14241. First published: 07 April 2018.
Source | Full text | Similar articles



.

Hawken SR, Spratt DE, Qi J, Linsell SM, Cher ML, Ghani KR, Miller DC, Montie JE, Morgan TM; Michigan Urological Surgery Improvement Collaborative.
Utilization of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy.
Int J Radiat Oncol Biol Phys. 2019 Jan 22. pii: S0360-3016(19)30046-X. doi: 10.1016/j.ijrobp.2019.01.006. [Epub ahead of print]
Source | Abstract | Similar articles



.

Lumbiganon S, Patcharatrakul S, Khongcharoensombat W, Sangkum P.
Pre- and post-radical prostatectomy testosterone levels in prostate cancer patients.
Int J Impot Res. 2019 Jan 18. doi: 10.1038/s41443-019-0116-0. [Epub ahead of print]
Source | Full text | Similar articles



bottom